AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Kinphos 40mg Injection

Prescription Icon
Prescription Required

Marketer

Alembic Pharmaceuticals Ltd

Salt Composition

Chloroquine (40mg)

Overview Kinphos 40mg Injection

Malarone 40mg Injection combats malaria parasites, preventing and treating the infection. Its mechanism involves eliminating the malaria-causing organism, halting disease progression. Administration is strictly by a healthcare provider; self-injection is prohibited. Prevent mosquito bites by using repellent on exposed skin, spraying indoor areas, and wearing light-colored, protective clothing after dusk. Potential side effects include weakness, nausea, vomiting, rash, itching, abdominal discomfort, diarrhea, and appetite loss. Injection site reactions (pain, swelling, redness) may also occur. Persistent side effects warrant medical attention. Diabetics should inform their doctor, as Kinphos 40mg Injection may lower blood glucose; regular blood sugar monitoring is crucial. Blurred vision may occur, necessitating regular eye exams. Prolonged use may require regular blood cell count monitoring. Report unexplained bruising/bleeding, sore throat, fever, or fatigue to your physician immediately.

Uses of Kinphos 40mg Injection

Managing Malaria Infections

Major Benefits of Kinphos 40mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Kinphos 40mg Injection:

  • Weakness
  • Rash
  • Headache
  • Dizziness
  • Vomiting
  • Nausea
  • Stomach pain
  • Loss of appetite
  • Diarrhea

How to use Kinphos 40mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Kinphos 40mg Injection works:

Malaria is effectively combated by Kinphos 40mg Injection, an antiparasitic agent. Its mechanism involves elevating blood haem levels, a compound lethal to the malaria parasite, thereby eliminating the parasite and halting disease progression.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Kinphos 40mg Injection may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Kinphos 40mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Kinphos 40mg Injection poses minimal risk during lactation. Research in humans indicates negligible transfer to breast milk, presenting no appreciable danger to the infant.

DrivingDrivingUNSAFE

Administering Kinphos 40mg Injection may induce adverse reactions impacting driving capabilities. Blurred vision or impaired visual focus, sometimes resulting from Kinphos 40mg Injection, can similarly compromise safe driving.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Kinphos 40mg Injection with care, as dose modification may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with hepatic impairment should use Kinphos 40mg Injection cautiously, potentially requiring dosage modification. A physician's consultation is recommended. Routine monitoring of liver function is advisable during treatment.

What if you forget to take Kinphos 40mg Injection :

NA

Facts to Know About Kinphos 40mg Injection

LabelValue
Pharmaceutical Category 4-Aminoquinoline-based compound
Potential for Dependence None.
Medication Classification Eye medication
Mechanism of Action Malaria medications: Aminoquinoline class

FAQs on Kinphos 40mg Injection

Malarone 40mg Injection treats and prevents malaria.
Malaria symptoms can emerge within a week of an infected mosquito bite. The onset of symptoms typically ranges from seven to eighteen days post-infection. Early malaria symptoms mimic influenza, encompassing chills, fever, myalgia, nausea, cephalalgia, and diarrhea.
Prolonged use of Kinphos 40mg Injection, as directed by your physician, necessitates regular eye examinations. This is a precaution due to the chloroquine content, which can induce blurred vision, reading difficulties (characterized by word loss), and, infrequently, retinopathy with extended treatment.
Consult your physician regarding any history of psoriasis prior to administering Kinphos 40mg Injection, as it could potentially exacerbate the condition.
This medication may cause abdominal discomfort, nausea, vomiting, or headache in some patients. These adverse reactions frequently lessen when the medication is administered with food.
Insufficient clinical evidence supports the use of chloroquine for COVID-19 treatment. Consequently, using Kinphos 40mg Injection for this purpose without physician consultation is not recommended.
Allow at least four hours to elapse between taking an antacid and other medications.
Both hydroxychloroquine and chloroquine initially received regulatory approval for malaria treatment. Hydroxychloroquine, however, exhibits a more favorable side effect profile compared to chloroquine. Consequently, hydroxychloroquine enjoys greater current usage. Furthermore, unlike chloroquine, hydroxychloroquine holds approvals for treating rheumatoid arthritis and lupus.
Protecting yourself from malaria involves precautions such as wearing clothing that covers exposed skin to deter mosquito bites, employing mosquito nets, and using insect repellent. Consult your physician regarding the necessity of antimalarial medication. If prescribed, ensure accurate dosage and completion of the full treatment regimen.
Malarone 40mg Injection combats malaria, serving both as a treatment and preventative measure.
Malaria symptoms can emerge within a week of an infected mosquito bite. However, the onset of symptoms typically ranges from seven to eighteen days post-infection. Early malaria symptoms mimic influenza, encompassing chills and fever, myalgia, nausea, cephalalgia, and diarrhea.
Prolonged use of Kinphos 40mg Injection, as prescribed by your physician, necessitates regular eye examinations. This is a precaution due to the chloroquine content, which may induce blurred vision, reading difficulties (manifesting as word loss), and, infrequently, retinopathy with extended treatment.
Consult your physician regarding any history of psoriasis prior to administering Kinphos 40mg Injection, as it could potentially exacerbate the condition.
Abdominal discomfort, nausea, vomiting, and headache are frequently reported among users of this medication. Consuming the medication with food may lessen the occurrence of these adverse reactions.
Insufficient clinical evidence supports the use of chloroquine in COVID-19 treatment. Consequently, using Kinphos 40mg Injection for this purpose without physician consultation is not recommended.
Allow at least four hours to elapse between taking an antacid and other medications.
Both hydroxychloroquine and chloroquine initially gained approval as antimalarial drugs. Hydroxychloroquine, however, exhibits a superior safety profile compared to chloroquine, which is associated with a higher incidence of adverse reactions. Consequently, hydroxychloroquine enjoys greater current usage. Furthermore, unlike chloroquine, hydroxychloroquine is also indicated for rheumatoid arthritis and lupus.
Mosquito-borne malaria can be avoided through preventative measures such as wearing long sleeves and trousers to deter bites, employing mosquito nets, and using insect repellent. Consult your physician regarding the necessity of antimalarial medication. If prescribed, ensure accurate dosage and completion of the entire course of the prescribed antimalarial drug.
Kinphos 40mg Injection
7
MRP 9
20% off